Drayson's Sensyne Health trades up 8.6% after IPO on AIM

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Drayson's Sensyne Health trades up 8.6% after IPO on AIM

Lord Drayson PA 230x150
Minister of Science in the Department for Business, Innovation and Skills, Lord Drayson, test drives the T.25, a petrol version of the T.27, the new all-electric urban car developed by Gordon Murray Design and Zytek Automotive Technology, at Dunsfold Aerodrome in Cranleigh, Surrey. | Matt Faber/PA Archive/PA Images

Sensyne Health, the UK healthcare artificial intelligence company, has traded up nicely after the company priced its IPO on London’s alternative investment market (AIM).

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article